Scorpius Holdings Inc.
SCPX
Get informed when a big investor buys or sells
+ FollowMarket Cap$16.1K
Close$
Share Statistics
| Market cap | $16,104.00 |
|---|---|
| Enterprise Value | $19.15 Trillion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-13.04 |
| Beta | -5.64 |
| Outstanding Shares | 61,143,000 |
Return
| Return on Equity | 2848.21% |
|---|---|
| Return on Assets | -182.33% |
| Return on Invested Capital | 2850.63% |
Valuation & Multiples
| P/E Ratio | 0 |
|---|---|
| PEG | 0 |
| Price to Sales | 0.0 |
| Price to Book Ratio | -0.0 |
| Enterprise Value to Revenue | 2.86 |
| Enterprise Value to EBIT | -0.47 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 1.03 |
| Debt to Equity | -14.84 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 29, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Scorpius Holdings Inc.
25 employees
CEO: Jeffrey Wolf heat biologics is a clinical-stage company focused on developing its proprietary impact™ (immune pan-antigen cytotoxic therapy), a fully allogeneic (“off-the-shelf”) cell-based immunotherapy for use in the treatment of a wide range of ca...